MAPT and Alzheimer disease: Numerous diagnostic clinical trials have been conducted to investigate the efficacy of brain imaging techniques that specifically target tau proteins to enhance early detection and monitoring of AD.[24] The primary objective of these trials was to gain a comprehensive understanding of the pathogenic pathways underlying AD.